Загрузка...
Emerging Immunopharmacological Targets in Multiple Sclerosis
Inflammatory demyelination of the central nervous system (CNS) is the hallmark of multiple sclerosis (MS), a chronic debilitating disease that affects more than 2.5 million individuals worldwide. It has been widely accepted, although not proven, that the major pathogenic mechanism of MS involves mye...
Сохранить в:
| Опубликовано в: : | J Neurol Sci |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215047/ https://ncbi.nlm.nih.gov/pubmed/26440421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2015.09.346 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|